Sentences with phrase «for generic drug maker»

After graduating with degrees in psychology and social work — both of which Witt says are extremely beneficial in real estate — she worked as a marketing coordinator for generic drug maker Pharmascience, organizing activities for 40 sales reps.

That's an even rarer feat for a generic drug maker such as Mylan, which makes most of its revenue not on brand - name drugs, but on cheaper, equivalent versions of other companies» branded medications.

Not exact matches

Daiichi Sankyo's press release comes in the wake not only of Ranbaxy's highly unusual criminal guilty plea and $ 500 million in fines and penalties — the largest ever against a generic - drug maker — but also a lengthy Fortune article that exposed for the first time the depth and extent of the fraud charges leveled at the company and the knowledge of senior company executives.

JERUSALEM — Israeli generic drug maker Teva Pharmaceutical Industries on Thursday said first - quarter earnings surged over 80 percent and raised its outlook for the rest of the year, citing progress in an aggressive restructuring plan.

A spokesman on Monday said that its Kabi subsidiary, a maker of generic drugs for injection and infusion, would expand its existing business to reach that goal.

It's the first so - called «pay for delay» case brought by the commission in which a drug's original maker agreed not to sell its own «authorized generic» version until well after a generic drugmaker began selling its product.

• PLIVA vs. Mensing: Ruled that makers of generic drugs can not be sued for failing to warn patients of new dangers or side effects.

Drug maker Mylan said it will offer a generic version of the life - saving allergy treatment EpiPen for half the list price of the brand - name treatment after it became the center of a national controversy over skyrocketing drug priDrug maker Mylan said it will offer a generic version of the life - saving allergy treatment EpiPen for half the list price of the brand - name treatment after it became the center of a national controversy over skyrocketing drug pridrug prices.

«A civil war has broken out among the most powerful players in the pharmaceutical industry — including brand - name and generic drug makers, and even your local pharmacists — with each blaming others for the rising price of medicine.»

Increasingly, international donors are withdrawing support from these countries, and drug makers such as Gilead are likely to see them as untapped markets for their products and thus exclude them from generic licensing deals.

Amgen (# 13 this year, down from # 6 in 2011) purchased Turkey's Mustafa Nevzat Pharmaceuticals, a maker of injectable generic drugs, for $ 700 million.

Indian drug maker Ranbaxy Laboratories Ltd. is facing harsh criticism after issuing a recall for more than 60,000 bottles of its generic cholesterol - lowering drug Lipitor.

The US Supreme Court will hear the issue of whether the makers of generic drugs can be sued for products liability despite the fact that federal law bars such lawsuits from proceeding.